In this episode of Looking Ahead with Blair Jones, Managing Director at Semler Brossy Consulting Group LLC, and Judy Zagorski, EVP of Global Human Resources at Church & Dwight Co., Inc, we focus on key issues specific to succession planning, its intersection with compensation, who should be involved in the process, and more.
As CEOs take pay cuts to show solidarity with workers, compensation committees are turning to building bonus structures for 2021 and beyond. But the process of tying bonuses to the right metrics to incentivize management has changed under the current economic landscape.
The economics of running a factory have changed, due to the rise of Covid-19. It’s allowing for smaller factories to implement more technological solutions, while keeping employees safer.
Social distancing could become the new normal for months to come, until a vaccine develops. Here’s how some companies have adapted to these new rules.
Even as companies tip-toe back to full operations again, the threat of a second wave of Covid-19 spread remains high. Boards must use this window to make changes, in case the impact of the second wave is higher than the first.
Boards must prepare for when things begin returning to normal again. How a company bounces back from this devastation could determine its survival.
In the fallout of COVID-19, technology has become the one sector that has uniquely benefited from the isolated workforce and the need for novel medicine. But the reliance on tech, medical technology and biotechnology in this uncertain time has provided opportunities for non-tech firms to unite with tech and medical leaders as well.
The COVID-19 crisis left organizations in a tough spot. How boards reacted in the face of this pressure may leave them liable, according to recent situations with similar outbreaks and illnesses.
JPMorgan Chase & Co. announced that Chairman and CEO Jamie Dimon had to undergo emergency heart surgery. An emergency medical situation – or worse – impacting the person in the CEO role can forever damage a company, a scare that no board wants to deal with. But they can prepare, just in case.
The healthcare industry has been a fountain of dealmaking lately. Companies wanting to make acquisitions or sell businesses this year should learn from the experts.